WRKY14 Antibody

What is WRKY14 and what is its function in plants?

WRKY14 (also known as ABNORMAL THERMOMORPHOGENESIS 1, ABT1, AR411, or WRKY DNA-BINDING PROTEIN 14) is a transcription factor belonging to Group II-e of the WRKY transcription factor family in Arabidopsis thaliana. It plays crucial roles in repressing plant thermomorphogenesis, which refers to the morphological changes plants undergo in response to elevated temperatures . Like other WRKY transcription factors, WRKY14 contains a conserved WRKY domain and a distinctive N-terminal coiled-coil (CC) domain composed of two alpha-helices, which are exclusively conserved in group IId WRKY transcription factors .

How does WRKY14 differ from other WRKY transcription factors?

WRKY14 belongs specifically to Group II-e of the WRKY transcription factor family. While all WRKY proteins contain the conserved WRKY domain that recognizes the W-box motif in promoter regions, WRKY14 contains a distinctive N-terminal coiled-coil (CC) domain composed of two alpha-helices that distinguishes it from other WRKY groups . Unlike some WRKY transcription factors that function as transcriptional activators, Group IId WRKY proteins like WRKY14 generally function as transcriptional repressors, modulating specific target genes involved in processes such as thermomorphogenesis .

What is the molecular structure and weight of WRKY14?

WRKY14 is a protein with an expected/apparent molecular weight of 47 kDa . Structurally, it contains a conserved WRKY domain responsible for DNA binding and an N-terminal coiled-coil (CC) domain. The CC domain facilitates protein-protein interactions, particularly with other regulatory proteins such as OBERON (OBE) proteins, which contain PHD finger domains . This interaction forms part of larger protein complexes that regulate gene expression in plants.

What are the key specifications of anti-WRKY14 antibodies for research?

Commercial anti-WRKY14 antibodies are typically rabbit polyclonal antibodies raised against a KLH-conjugated synthetic peptide derived from the C-terminal section (approximately 15 amino acids) of Arabidopsis thaliana WRKY14 (AT1G30650) . These antibodies have high specificity for WRKY14 and can be used for various applications, most commonly Western blotting. The recommended dilution for Western blot applications is typically 1:1000-1:2000, although optimal dilutions should be determined by the end user based on their specific experimental conditions .

How should researchers validate a new batch of WRKY14 antibody?

To validate a new batch of WRKY14 antibody, researchers should:

• Perform Western blot analysis using positive controls (e.g., Arabidopsis extract from wild-type plants) and negative controls (e.g., WRKY14 knockout mutants).

• Verify the detection of a single band at the expected molecular weight (47 kDa).

• Test antibody specificity using competitive blocking with the immunizing peptide.

• Conduct dose-response experiments to determine optimal antibody concentration.

• If possible, validate using alternative methods such as immunoprecipitation followed by mass spectrometry.

This validation is essential for ensuring experimental reliability and reproducibility in subsequent studies.

What are the optimal conditions for using WRKY14 antibody in Western blot experiments?

For optimal Western blot results with WRKY14 antibody:

• Use fresh plant tissue or flash-frozen samples to minimize protein degradation.

• Extract proteins using a buffer containing protease inhibitors to prevent degradation.

• Resolve proteins on 10-12% SDS-PAGE gels to properly separate the 47 kDa WRKY14 protein.

• Transfer proteins to PVDF or nitrocellulose membranes.

• Block with 5% non-fat dry milk or BSA in TBST.

• Use the antibody at a 1:1000-1:2000 dilution in blocking buffer.

• Incubate overnight at 4°C for optimal binding.

• Wash thoroughly with TBST to reduce background.

• Use appropriate HRP-conjugated secondary antibodies and ECL detection systems .

Optimization may be necessary depending on the specific experimental setup and plant material.

How can WRKY14 antibody be used to study protein-protein interactions in planta?

WRKY14 antibody can be effectively used for studying protein-protein interactions through several approaches:

• Co-immunoprecipitation (Co-IP): Use WRKY14 antibody to pull down WRKY14 protein complexes from plant extracts, followed by Western blot analysis to detect interacting partners. Research has shown that Group IId WRKY transcription factors interact with OBERON (OBE) proteins through their conserved N-terminal coiled-coil domain .

• Chromatin Immunoprecipitation (ChIP): Use WRKY14 antibody to identify DNA regions bound by WRKY14 in vivo, which can help identify target genes.

• Proximity-dependent labeling: Combine WRKY14 antibody with techniques like BioID or APEX to identify proteins in close proximity to WRKY14.

• Immunofluorescence microscopy: Use WRKY14 antibody together with antibodies against potential interacting proteins to visualize co-localization in plant cells.

These approaches can reveal how WRKY14 interacts with other proteins to form functional complexes that regulate plant thermomorphogenesis and immunity.

Can WRKY14 antibody be used to study post-translational modifications of the protein?

Yes, WRKY14 antibody can be valuable for studying post-translational modifications (PTMs) of WRKY14. Research on related WRKY transcription factors indicates that they are subject to various PTMs that regulate their function, stability, and activity. For instance:

• Phosphorylation: WRKY70, another WRKY family member, undergoes phosphorylation at specific residues (Thr22 and Ser34), which activates its binding to target gene promoters . WRKY14 may undergo similar regulation.

• Ubiquitination: Studies have shown that WRKY transcription factors can be polyubiquitinated and degraded via the 26S proteasome pathway . For example, OsWRKY7 has been shown to be a fast-turnover protein degraded via the ubiquitin/26S proteasome pathway .

To study these modifications:

• Use WRKY14 antibody to immunoprecipitate the protein

• Analyze by Western blot using antibodies specific for phosphorylation, ubiquitination, or other PTMs

• Alternatively, analyze the immunoprecipitated protein by mass spectrometry to identify specific modification sites

How should researchers interpret changes in WRKY14 protein levels during stress responses?

When interpreting changes in WRKY14 protein levels during stress responses:

• Consider protein stability regulation: Many WRKY proteins are regulated at the post-translational level. For instance, WRKY70 is degraded by the 26S proteasome via CHYR1-mediated ubiquitination after pathogen infection . WRKY14 may undergo similar regulation.

• Correlate with transcriptional changes: Compare protein levels with mRNA levels to determine whether regulation occurs at the transcriptional or post-transcriptional level.

• Examine temporal dynamics: Monitor WRKY14 levels at multiple time points to capture the dynamic nature of stress responses.

• Consider tissue specificity: WRKY14 expression and regulation may vary across different plant tissues.

• Analyze in context of other regulators: WRKY transcription factors often function in complex networks with other regulators. Changes in WRKY14 should be interpreted in this broader context.

Changes in WRKY14 levels likely reflect the plant's adaptation to stress conditions, particularly in response to temperature changes given its role in thermomorphogenesis .

What approaches can be used to distinguish between transcriptional and post-transcriptional regulation of WRKY14?

To distinguish between transcriptional and post-transcriptional regulation of WRKY14:

• Parallel analysis of mRNA and protein levels: Compare WRKY14 mRNA levels (via qRT-PCR) with protein levels (via Western blot using WRKY14 antibody) under various conditions. Discrepancies between mRNA and protein levels suggest post-transcriptional regulation.

• Protein stability assays: Treat plant samples with cycloheximide (to inhibit protein synthesis) and monitor WRKY14 degradation over time using the antibody. This can reveal the protein's half-life under different conditions.

• Proteasome inhibitor treatments: Treat samples with proteasome inhibitors like MG132 before Western blot analysis. Increased WRKY14 accumulation after treatment suggests regulation via the ubiquitin-proteasome pathway .

• Polysome profiling: Analyze WRKY14 mRNA association with ribosomes to assess translational regulation.

• PTM analysis: Use phosphorylation or ubiquitination-specific antibodies in combination with WRKY14 antibody to detect modified forms of the protein.

These approaches can provide a comprehensive understanding of the regulatory mechanisms controlling WRKY14 levels and activity in response to various stimuli.

How can researchers determine if WRKY14 is forming complexes with other proteins in vivo?

To determine if WRKY14 is forming complexes with other proteins in vivo:

• Co-immunoprecipitation followed by mass spectrometry: Use WRKY14 antibody to pull down protein complexes, then identify interacting partners via mass spectrometry. This approach has successfully identified interactions between Group IId WRKY transcription factors and OBERON (OBE) proteins in Arabidopsis .

• Gel filtration chromatography: This technique can be used to separate protein complexes based on size. Western blot analysis of fractions using WRKY14 antibody can reveal whether WRKY14 elutes in high-molecular-weight fractions, indicating complex formation. Research has shown that WRKY11 (another Group IId WRKY) and OBE1 primarily elute in high-molecular-weight fractions (~443 kDa) .

• Bimolecular Fluorescence Complementation (BiFC): This in vivo technique can visualize protein interactions in plant cells.

• Yeast two-hybrid (Y2H) assays: While an in vitro technique, Y2H can confirm direct interactions between WRKY14 and potential partners identified through co-IP/MS.

• Proximity ligation assay (PLA): This microscopy-based technique can detect protein interactions in situ with high sensitivity.

Research has shown that Group IId WRKY transcription factors interact with OBE proteins through their conserved N-terminal coiled-coil domain and form high-molecular-weight complexes in Arabidopsis .

What are common challenges when using WRKY14 antibody and how can they be addressed?

Common challenges when using WRKY14 antibody and their solutions include:

• High background in Western blots:

  • Increase blocking time or concentration

  • Use more stringent washing conditions

  • Optimize antibody dilution (try 1:2000 instead of 1:1000)

  • Use fresh blocking reagents

  • Consider alternative blocking agents (BSA instead of milk or vice versa)

• Weak or no signal:

  • Ensure proper protein extraction from plant tissues

  • Verify protein transfer efficiency

  • Increase antibody concentration or incubation time

  • Use enhanced chemiluminescence (ECL) substrates with higher sensitivity

  • Check for protein degradation during sample preparation

• Multiple bands or bands at unexpected sizes:

  • Use freshly prepared samples with protease inhibitors

  • Include phosphatase inhibitors if studying phosphorylated forms

  • Test specificity with peptide competition assays

  • Use WRKY14 knockout/knockdown plants as negative controls

  • Consider post-translational modifications or degradation products

• Poor reproducibility:

  • Standardize protein extraction and Western blot protocols

  • Use consistent incubation times and temperatures

  • Prepare fresh buffers for each experiment

  • Consider using an internal loading control

How can WRKY14 antibody protocols be modified for different plant species or tissues?

To adapt WRKY14 antibody protocols for different plant species or tissues:

• Protein extraction optimization:

  • For recalcitrant tissues (e.g., seeds, woody tissues): Use stronger extraction buffers with higher detergent concentrations

  • For tissues rich in phenolics: Add polyvinylpolypyrrolidone (PVPP) to the extraction buffer

  • For tissues rich in carbohydrates: Include additional purification steps before immunoprecipitation

• Cross-reactivity considerations:

  • For species closely related to Arabidopsis (e.g., Brassica species): The antibody should work with minimal modifications as sequence homology is 80-99%

  • For distant species: Verify cross-reactivity with preliminary Western blots

  • Consider higher antibody concentrations for species with lower sequence homology

• Immunoprecipitation adjustments:

  • Increase antibody amount for tissues with low WRKY14 expression

  • Adjust lysis conditions based on subcellular localization in specific tissues

  • For tissues with high proteolytic activity: Include additional protease inhibitors

• Signal detection optimization:

  • For tissues with high autofluorescence: Use chemiluminescence rather than fluorescence-based detection

  • For samples with low WRKY14 expression: Use more sensitive detection methods

What controls are essential when publishing research using WRKY14 antibody?

When publishing research using WRKY14 antibody, the following controls are essential:

• Positive controls:

  • Wild-type plant samples known to express WRKY14

  • Recombinant WRKY14 protein (if available)

  • Plants overexpressing WRKY14 (WRKY14-OE)

• Negative controls:

  • WRKY14 knockout or knockdown mutants

  • Non-transformed plants for comparison with transgenic lines

  • Secondary antibody-only controls to assess non-specific binding

• Specificity controls:

  • Peptide competition assays using the immunizing peptide

  • Detection of WRKY14 at the expected molecular weight (47 kDa)

  • Comparison with alternative methods of detection (e.g., epitope-tagged WRKY14)

• Loading and normalization controls:

  • Housekeeping proteins (e.g., actin, tubulin) for Western blots

  • Total protein staining (e.g., Ponceau S) for membrane loading verification

  • Consistent tissue sampling and processing procedures

• Experimental validation controls:

  • Biological replicates (minimum three independent experiments)

  • Technical replicates to demonstrate reproducibility

  • Appropriate statistical analyses to validate findings

Including these controls ensures research rigor and reproducibility, facilitating peer review and acceptance of findings by the scientific community.

How can WRKY14 antibody be used to study the dynamics of plant immune responses?

WRKY14 antibody can be instrumental in studying the dynamics of plant immune responses through several advanced approaches:

• Temporal profiling: Monitor WRKY14 protein levels at different time points after pathogen exposure or immune elicitor treatment. This can reveal the kinetics of WRKY14 involvement in immune signaling. Research on related WRKY proteins has shown their dynamic regulation during pathogen infection .

• Chromatin immunoprecipitation sequencing (ChIP-seq): Use WRKY14 antibody to identify genome-wide binding sites of WRKY14 during immune responses, revealing direct target genes involved in defense responses.

• Protein-protein interaction dynamics: Use co-immunoprecipitation with WRKY14 antibody followed by mass spectrometry to identify changes in WRKY14 interactome during pathogen challenge. Group IId WRKY transcription factors have been shown to form complexes with other proteins, including OBE proteins .

• Post-translational modification analysis: Monitor changes in WRKY14 phosphorylation, ubiquitination, or other modifications during immune responses. Research has shown that WRKY proteins like WRKY70 undergo phosphorylation and ubiquitination as regulatory mechanisms .

• Subcellular localization studies: Use WRKY14 antibody in immunofluorescence microscopy to track changes in WRKY14 localization during immune responses.

These approaches can provide comprehensive insights into how WRKY14 contributes to the complex signaling networks regulating plant immunity.

What techniques can combine WRKY14 antibody with proteomics to understand its role in stress signaling networks?

Combining WRKY14 antibody with proteomics offers powerful approaches to understand its role in stress signaling networks:

• Immunoprecipitation-mass spectrometry (IP-MS): Use WRKY14 antibody to pull down WRKY14 and its interacting partners, followed by mass spectrometry identification. This approach has been successfully used to identify protein-protein interactions involving Group IId WRKY transcription factors .

• Proximity-dependent biotin labeling (BioID or TurboID): Fuse a biotin ligase to WRKY14, express in plants, and use WRKY14 antibody to verify expression before proceeding with streptavidin pulldown and mass spectrometry to identify proteins in close proximity to WRKY14 in vivo.

• Parallel reaction monitoring (PRM): Use targeted proteomics to quantify specific phosphorylation sites or other PTMs on WRKY14 under different stress conditions, after verification of sites using the antibody for immunoprecipitation.

• Cross-linking immunoprecipitation (CLIP): Combine UV cross-linking with WRKY14 immunoprecipitation to identify RNA molecules directly bound by WRKY14, if RNA-binding activity is suspected.

• Protein correlation profiling: Use size exclusion chromatography followed by mass spectrometry, with WRKY14 antibody to track specific fractions containing WRKY14, to identify co-eluting proteins that may form complexes with WRKY14.

These integrated approaches can reveal how WRKY14 functions within larger protein complexes to coordinate stress responses in plants.

How does the function of WRKY14 compare with other WRKY proteins in plant immunity?

WRKY transcription factors play diverse roles in plant immunity, with both positive and negative regulators identified:

• WRKY14 (Group II-e): Functions primarily in the repression of plant thermomorphogenesis , but its specific role in immunity is less well-characterized compared to other WRKY proteins.

• Group IId WRKYs (WRKY7, WRKY11, WRKY15, WRKY17, WRKY21, WRKY39): These WRKY proteins, which share structural similarity with WRKY14, are involved in the repression of basal resistance to Pseudomonas syringae . They form complexes with OBERON (OBE) proteins through their conserved N-terminal coiled-coil domain .

• WRKY70: Functions as a key regulator balancing plant immunity and growth. WRKY70 undergoes phosphorylation at specific residues (Thr22 and Ser34) upon pathogen infection, which activates its binding to WT box elements in target gene promoters (such as SARD1). The phosphorylated form is later degraded via the 26S proteasome through CHYR1-mediated ubiquitination to restore normal growth after infection .

• VqWRKY56, VqWRKY31, VqWRKY6, VqWRKY52: These grape WRKY proteins regulate resistance to powdery mildew. For example, VqWRKY56 increases resistance by promoting the accumulation of proanthocyanidins, reactive oxygen species, and salicylic acid. It interacts with VqbZIPC22 to activate expression of genes involved in proanthocyanidin biosynthesis .

This comparison suggests that while certain WRKY proteins (like WRKY70) act as positive regulators of immunity, others (particularly Group IId WRKYs) function as negative regulators, highlighting the complex regulatory network involving WRKY transcription factors in plant defense responses.

How can researchers use antibodies to distinguish between closely related WRKY proteins?

Distinguishing between closely related WRKY proteins using antibodies requires careful consideration of their structural differences and experimental design:

• Epitope selection: Choose antibodies raised against unique regions of WRKY14, particularly outside the highly conserved WRKY domain. The C-terminal region (as used in commercial WRKY14 antibodies) often contains more variable sequences that can provide specificity .

• Validation strategies:

  • Use knockout/knockdown mutants of specific WRKY genes as negative controls

  • Use recombinant proteins of different WRKY family members to test cross-reactivity

  • Perform peptide competition assays using peptides from different WRKY proteins

• Size discrimination: Some WRKY proteins have different molecular weights that can be distinguished on Western blots. For example, WRKY14 has an expected molecular weight of 47 kDa , which may differ from other WRKY proteins.

• Combination approaches:

  • Use immunoprecipitation with a specific WRKY antibody followed by mass spectrometry for definitive identification

  • Employ epitope-tagged versions of WRKY proteins in transgenic plants for unambiguous detection

• 2D gel electrophoresis: Separate WRKY proteins based on both molecular weight and isoelectric point before Western blotting to better distinguish between closely related family members.

These approaches can help researchers accurately identify and study specific WRKY proteins despite the high sequence similarity within the family.

What experimental approaches can reveal functional redundancy between WRKY14 and other WRKY transcription factors?

To investigate functional redundancy between WRKY14 and other WRKY transcription factors:

• Genetic approaches:

  • Generate single and higher-order mutants (double, triple mutants) of WRKY14 and closely related WRKY genes

  • Compare phenotypes of single vs. multiple knockout lines under various conditions

  • Create complementation lines expressing different WRKY genes in a WRKY14 mutant background

• Transcriptome analysis:

  • Compare gene expression profiles of wild-type, WRKY14 mutant, and mutants of related WRKY genes

  • Identify overlapping sets of differentially expressed genes

  • Use WRKY14 antibody in ChIP-seq to identify direct targets and compare with targets of other WRKY proteins

• Protein interaction studies:

  • Use WRKY14 antibody in co-immunoprecipitation experiments to identify interacting partners

  • Compare with interactomes of other WRKY proteins

  • Research has shown that Group IId WRKY transcription factors interact with OBE proteins through their conserved CC domain

• Domain swap experiments:

  • Create chimeric proteins by swapping domains between WRKY14 and other WRKY proteins

  • Test functional complementation in WRKY14 mutant backgrounds

• Biochemical assays:

  • Compare DNA binding specificities of WRKY14 and related WRKY proteins

  • Assess transcriptional activation/repression activities in reporter assays

Research has already demonstrated functional redundancy among Group IId WRKY transcription factors, which form redundant WRKY-OBE complexes in Arabidopsis . Similar approaches could reveal whether WRKY14 shares redundant functions with these or other WRKY proteins.

How might emerging technologies enhance the utility of WRKY14 antibody in plant research?

Emerging technologies that could enhance the utility of WRKY14 antibody in plant research include:

• Single-cell proteomics: Combining WRKY14 antibody with single-cell protein analysis techniques could reveal cell-type-specific expression and regulation patterns of WRKY14, providing insights into its function in specific plant tissues.

• CRISPR-based tagging: CRISPR/Cas9-mediated endogenous tagging of WRKY14 with fluorescent proteins or epitope tags can facilitate in vivo studies while maintaining native expression levels, complementing antibody-based approaches.

• Spatial transcriptomics integration: Combining immunofluorescence using WRKY14 antibody with spatial transcriptomics could correlate WRKY14 protein localization with gene expression patterns in specific tissue regions.

• Live-cell imaging with nanobodies: Developing anti-WRKY14 nanobodies (small single-domain antibody fragments) for live-cell imaging could enable real-time visualization of WRKY14 dynamics during stress responses.

• Cryo-electron microscopy (cryo-EM): Using WRKY14 antibody to purify native protein complexes for structural analysis by cryo-EM could reveal detailed molecular mechanisms of WRKY14 function in transcriptional regulation.

• Protein-protein interaction mapping with proximity labeling: Combining proximity labeling techniques with WRKY14 antibody validation could create comprehensive maps of WRKY14 interaction networks in different cellular compartments.

These technologies could significantly advance our understanding of WRKY14's roles in plant development, stress responses, and immunity.

What are promising research avenues for understanding WRKY14's role in plant environmental adaptation?

Promising research avenues for understanding WRKY14's role in plant environmental adaptation include:

• Climate change response studies: Investigating WRKY14 expression and protein levels under elevated temperatures, drought, and combined stresses using WRKY14 antibody could reveal its role in climate adaptation, particularly given its known function in thermomorphogenesis .

• Interaction with stress hormone signaling pathways: Exploring how WRKY14 integrates with abscisic acid, jasmonate, and ethylene signaling during environmental stress could uncover its position in stress response networks.

• Epigenetic regulation: Investigating how epigenetic modifications affect WRKY14 expression and function under stress conditions, potentially using WRKY14 antibody in ChIP experiments examining histone modifications at the WRKY14 locus.

• Cross-talk between abiotic and biotic stress responses: Examining WRKY14's role in coordinating responses to simultaneous biotic and abiotic stresses, a common scenario in natural environments.

• Evolution of WRKY14 function across species: Comparative studies using WRKY14 antibody across different plant species could reveal how WRKY14 function has evolved to enable adaptation to diverse environments.

• Roles in plant development under stress: Investigating how WRKY14 balances developmental programs with stress responses, similar to the role of WRKY70 in balancing immunity and growth .

These research directions could provide valuable insights into how plants adapt to changing environments and could inform strategies for developing climate-resilient crops.

How can systems biology approaches incorporating WRKY14 antibody data advance our understanding of plant transcriptional networks?

Systems biology approaches incorporating WRKY14 antibody data can significantly advance our understanding of plant transcriptional networks through:

• Multi-omics data integration: Combining WRKY14 antibody-based proteomics data with transcriptomics, metabolomics, and phenomics to create comprehensive models of regulatory networks involving WRKY14. This could reveal how WRKY14 coordinates different cellular processes during environmental responses.

• Network modeling: Using WRKY14 antibody in ChIP-seq experiments to identify direct targets, then integrating this data with protein-protein interaction networks to model how WRKY14 functions within larger transcriptional complexes. Research has shown that WRKY proteins form complexes with other regulatory proteins, such as the WRKY-OBE complexes in Arabidopsis .

• Temporal dynamics analysis: Using WRKY14 antibody to track protein levels, modifications, and interactions over time following stress exposure, then incorporating these dynamics into mathematical models of stress response networks.

• Comparative systems analysis: Applying WRKY14 antibody in studies across multiple plant species to identify conserved and divergent aspects of WRKY14-containing regulatory networks.

• Perturbation-based network inference: Combining WRKY14 antibody-based measurements with systematic perturbations (genetic modifications, environmental changes) to infer causal relationships within transcriptional networks.

• Feedback loop identification: Using WRKY14 antibody data to identify and characterize feedback loops in transcriptional networks, which are critical for adaptive responses to environmental changes.